Skip to content
Polis

House bill · 89R

HB 3176

Relating to the manufacture, sale, and distribution of products developed using mRNA material in the prevention or treatment of a communicable disease.

Did not pass

Progress

27 days from first to latest action, across 3 recorded actions.

  1. Filed

    Feb 21

  2. Referred to committee

    Mar 20

  3. Heard in committee

    Stopped here

  4. Reported from committee

  5. Passed first chamber

  6. Passed second chamber

  7. Sent to governor

  8. Became law

HouseMar

Filled marks are milestones (committee report, floor passage, governor action). Larger marks hold more same-day actions.

Full history

Every action recorded by Texas Legislature Online.

  1. Referred to Public Health Public Health

    Mar 20, 2025 · House

  2. Read first time

    Mar 20, 2025 · House

  3. Filed

    Feb 21, 2025 · House

Authors

and 16 coauthors or sponsors

Show 16 more
  • Helen Kerwin cosponsorR
  • Katrina Pierson cosponsorR
  • Shelby Slawson cosponsorR
  • Mitch Little cosponsorR
  • Ben Bumgarner cosponsorR
  • Valoree Swanson cosponsorR
  • Richard Hayes cosponsorR
  • Briscoe Cain cosponsorR
  • Nate Schatzline cosponsorR
  • Brent Money cosponsorR
  • Tony Tinderholt cosponsorR
  • Will Metcalf cosponsorR
  • Steve Toth cosponsorR
  • Carrie Isaac cosponsorR
  • Don McLaughlin cosponsorR
  • Andy Hopper cosponsorR

In committee

Topics

Bill text

Bills on similar topics

Other legislation this session sharing the most index topics.

HB 3176 (89R) · Polis